Variant isoforms of CD44 are required in early thymocyte development
✍ Scribed by Christoph Schwärzler; Snezhana Oliferenko; Ursula Günthert
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 201 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
To clarify the possible role of CD44 in the development or progression of uterine cervical tumours, an immunohistochemical investigation was carried out on 125 cases of cervical intraepithelial neoplasia (CIN), 78 invasive squamous cell carcinomas (ISCC), 61 cervical adenocarcinomas (AC), nine adeno
CD44 is a glycosylated adhesion molecule which may undergo alternative splicing of 10 possible exons to generate variant isoforms. A number of CD44 variant isoforms expressed by tumor cells have been correlated with metastatic and proliferative behavior. In this study, we have characterized CD44 iso
Immunolocalization of E-cadherin (E-cad), ␣-catenin, -catenin, and CD44 has rarely been investigated in human cholangiocarcinoma (CC). We, therefore, immunohistochemically examined the expression of E-cad, ␣-catenin, -catenin, CD44 standard (CD44s), and CD44 variants (CD44v) including CD44v5, CD44
## BACKGROUND. Variant CD44 splice products, especially CD44 variant 6 (CD44v6),